Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) on February 4, 2016. The filing serves to announce the company's financial results for the fourth quarter and full year ended December 31, 2015.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release attached as Exhibit 99.1, which is not included in the source text.
Material Changes
The filing does not provide specific data regarding material changes versus prior periods. It solely references the issuance of a press release containing the comparative financial results.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The filing explicitly states that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference unless expressly stated otherwise.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q4 and full-year 2015 by reviewing Exhibit 99.1 (the press release).
- Confirm the company's cash position and liquidity status as detailed in the attached financial results.
- Review the press release for any updated guidance or outlook for 2016.
- Note that the financial data in this 8-K is not incorporated by reference into other SEC filings unless specifically cited.